Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q1 2020 · 10-Q
Revenue$2.12B$2.12B−9.7% vs Q1 2019 Net Income-$11.32M-$11.32MN/M vs Q1 2019 EPS Diluted-$0.19-$0.19N/M vs Q1 2019 Gross Profit$268,559,000−2.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flow$93,454,000N/M Free Cash Flowderived$88,683,000N/M Margins · derivedGross margin12.7%+0.9 pt vs Q1 2019
Operating margin0.5%−0.2 pt vs Q1 2019
Net margin-0.5%+0.1 pt vs Q1 2019
ended Mar 31, 2020 · filed May 6, 2020 · 36 d after period end